Kaempferol impedes IL-32-induced monocyte-macrophage differentiation.

[1]  Hyung‐Min Kim,et al.  Attenuation of IL-32-induced caspase-1 and nuclear factor-κB activations by acteoside. , 2015, International immunopharmacology.

[2]  Z. Peng,et al.  IL‐32 was involved in cigarette smoke‐induced pulmonary inflammation in COPD , 2015, The clinical respiratory journal.

[3]  A. Sureda,et al.  Kaempferol and inflammation: From chemistry to medicine. , 2015, Pharmacological research.

[4]  I. Nishigaki,et al.  Kaempferol, a potential cytostatic and cure for inflammatory disorders. , 2014, European journal of medicinal chemistry.

[5]  Kun-Young Park,et al.  Inhibition of IL-32 signaling by bamboo salt decreases pro-inflammatory responses in cellular models of allergic rhinitis. , 2014, Journal of medicinal food.

[6]  S. Horvath,et al.  IL-32 is a molecular marker of a host defense network in human tuberculosis , 2014, Science Translational Medicine.

[7]  Myong-Jo Kim,et al.  Pulmonary , gastrointestinal and urogenital pharmacology Evaluation of the effect of kaempferol in a murine allergic rhinitis model , 2013 .

[8]  N. Mukaida,et al.  Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. , 2013, Immunity.

[9]  Na‐Ra Han,et al.  Interleukin-32-induced thymic stromal lymphopoietin plays a critical role in macrophage differentiation through the activation of caspase-1 in vitro , 2012, Arthritis Research & Therapy.

[10]  Hyung‐Min Kim,et al.  Therapeutic effects of traditional Korean medicine, Jeechool-Whan in allergic rhinitis model , 2012 .

[11]  E. Pamer,et al.  Monocyte recruitment during infection and inflammation , 2011, Nature Reviews Immunology.

[12]  M. Shaw,et al.  Inflammatory response of porcine epithelial IPEC J2 cells to enterotoxigenic E. coli infection is modulated by zinc supplementation. , 2011, Molecular immunology.

[13]  Hyung‐Min Kim,et al.  IL‐32 up‐regulation is associated with inflammatory cytokine production in allergic rhinitis , 2011, The Journal of pathology.

[14]  S. Ziegler.  The role of thymic stromal lymphopoietin (TSLP) in allergic disorders. , 2010, Current opinion in immunology.

[15]  Won‐Kyo Jung,et al.  Evaluation of anti-inflammatory effect of fucoxanthin isolated from brown algae in lipopolysaccharide-stimulated RAW 264.7 macrophages. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[16]  C. Akdis,et al.  IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. , 2010, The Journal of allergy and clinical immunology.

[17]  F. Geissmann,et al.  Blood monocytes: development, heterogeneity, and relationship with dendritic cells. , 2009, Annual review of immunology.

[18]  Y. Zhang,et al.  Overexpression of thymic stromal lymphopoietin in allergic rhinitis , 2009, Acta oto-laryngologica.

[19]  C. Dinarello,et al.  IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[20]  D. Yoon,et al.  Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining. , 2008, Journal of microbiology and biotechnology.

[21]  K. Friedrich,et al.  Signal transduction around thymic stromal lymphopoietin (TSLP) in atopic asthma , 2008, Cell Communication and Signaling.

[22]  T. Hohl,et al.  Monocyte-mediated defense against microbial pathogens. , 2008, Annual review of immunology.

[23]  L. Joosten,et al.  Interleukin-32 induces the differentiation of monocytes into macrophage-like cells , 2008, Proceedings of the National Academy of Sciences.

[24]  F. Brennan,et al.  Update on cytokines in rheumatoid arthritis , 2007, Current opinion in rheumatology.

[25]  I. McInnes,et al.  Emerging cytokine targets in rheumatoid arthritis , 2007, Current opinion in rheumatology.

[26]  C. Dinarello,et al.  IL-32, a novel cytokine with a possible role in disease , 2006, Annals of the rheumatic diseases.

[27]  V. Devauchelle,et al.  Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. , 2005, European cytokine network.

[28]  M. Netea,et al.  IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Weitzman,et al.  Chronic inflammation and cancer. , 2002, Oncology.

[30]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[31]  N. Goh,et al.  Separation of kaempferols in Impatiens balsamina flowers by capillary electrophoresis with electrochemical detection , 2001 .

[32]  M. Joseph,et al.  Production of chemokines and proinflammatory and antiinflammatory cytokines by human alveolar macrophages activated by IgE receptors. , 1999, The Journal of allergy and clinical immunology.

[33]  R. Perlmutter,et al.  Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. , 1999, Journal of immunology.

[34]  L. Borish,et al.  Regulation of low affinity IgE receptor (CD23) expression on mononuclear phagocytes in normal and asthmatic subjects. , 1992, Journal of immunology.

[35]  A. Capron,et al.  Tumor necrosis factor alpha and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation. , 1992, The American review of respiratory disease.

[36]  L. Borish,et al.  IgE-dependent cytokine production by human peripheral blood mononuclear phagocytes. , 1991, Journal of immunology.

[37]  J. Rankin,et al.  The contribution of alveolar macrophages to hyperreactive airway disease. , 1989, The Journal of allergy and clinical immunology.

[38]  Baek Kim,et al.  Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophages. , 2012, International immunopharmacology.

[39]  D. Yoon,et al.  Interleukin-32: a cytokine and inducer of TNFalpha. , 2005, Immunity.

[40]  J. Bousquet,et al.  IL-4 and IgE-anti-IgE modulation of 15(S)-hydroxyeicosatetraenoic acid release by mononuclear phagocytes. , 1999, The Journal of allergy and clinical immunology.

[41]  P. Demoly,et al.  IgE produces monocyte superoxide anion release: correlation with CD23 expression. Comparison of patients with asthma, patients with rhinitis, and normal subjects. , 1994, The Journal of allergy and clinical immunology.